AU6771598A - Estrogen and the mental state: molecular variations within the estrogen receptorgene modulate clinical susceptibility to depression - Google Patents

Estrogen and the mental state: molecular variations within the estrogen receptorgene modulate clinical susceptibility to depression

Info

Publication number
AU6771598A
AU6771598A AU67715/98A AU6771598A AU6771598A AU 6771598 A AU6771598 A AU 6771598A AU 67715/98 A AU67715/98 A AU 67715/98A AU 6771598 A AU6771598 A AU 6771598A AU 6771598 A AU6771598 A AU 6771598A
Authority
AU
Australia
Prior art keywords
estrogen
receptorgene
modulate
depression
mental state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67715/98A
Other languages
English (en)
Inventor
Stephen J. Peroutka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPECTRA BIOMEDICAL
Original Assignee
SPECTRA BIOMEDICAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPECTRA BIOMEDICAL filed Critical SPECTRA BIOMEDICAL
Publication of AU6771598A publication Critical patent/AU6771598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/304—Mood disorders, e.g. bipolar, depression

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU67715/98A 1997-03-24 1998-03-23 Estrogen and the mental state: molecular variations within the estrogen receptorgene modulate clinical susceptibility to depression Abandoned AU6771598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4144997P 1997-03-24 1997-03-24
US60041449 1997-03-24
PCT/US1998/005789 WO1998042872A1 (fr) 1997-03-24 1998-03-23 Oestrogenes et etat mental: variations moleculaires du recepteur de l'oestrogene modulatrices de la susceptibilite a la depression

Publications (1)

Publication Number Publication Date
AU6771598A true AU6771598A (en) 1998-10-20

Family

ID=21916567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67715/98A Abandoned AU6771598A (en) 1997-03-24 1998-03-23 Estrogen and the mental state: molecular variations within the estrogen receptorgene modulate clinical susceptibility to depression

Country Status (3)

Country Link
EP (1) EP0983382A1 (fr)
AU (1) AU6771598A (fr)
WO (1) WO1998042872A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1573055A4 (fr) * 2002-09-24 2006-05-10 Univ Colorado Regents Diagnostic genetique de depression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5563035A (en) * 1994-06-16 1996-10-08 The Board Of Trustees Of The Leland Stanford Junior University Estrogen receptor regulation and its uses

Also Published As

Publication number Publication date
EP0983382A1 (fr) 2000-03-08
WO1998042872A1 (fr) 1998-10-01

Similar Documents

Publication Publication Date Title
AU2103097A (en) Cinnoline derivatives and use as medicine
EP0926468B8 (fr) Dispositif d'affichage
AU8127998A (en) Quinoline compounds and medicinal uses thereof
HUP0001971A3 (en) Soluble ctla4 mutant molecules and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU8173098A (en) Neuroprotective methods and reagents
AU1387399A (en) Probucol esters and uses thereof
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU6962698A (en) Transgenomic viruses and the use thereof
AU6119398A (en) Phenylpropenone compounds and medicines containing the same
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU4152200A (en) Sensing system and use thereof
AU6771598A (en) Estrogen and the mental state: molecular variations within the estrogen receptorgene modulate clinical susceptibility to depression
AU7681498A (en) Pharmaceutical composition and use thereof
AU2897500A (en) "rzao" steering and variants
AU1664299A (en) Autodegradable microcarriers and their use
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
AU7678898A (en) New carbohydrates and use thereof
AU7024500A (en) Essential genes and assays relating thereto
AU7151498A (en) Neuroprotective compounds and uses thereof
IL132174A0 (en) Phenoketals and the use thereof as odoriferous substances
AU5343498A (en) Thiophene compounds and medicinal use thereof
AUPP263498A0 (en) Novel therapeutic molecules and uses therefor
AU8729298A (en) Novel azulene derivatives and medicaments with a metalloprotein-inhibiting effect containing said derivatives
AU6601098A (en) Vaccine and assay